Search Results - "Cheuk, Adam"

Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma.

Authors: Wu, Jerry T. Cheuk, Adam Isanogle, Kristine et al.

Source: Cancers. Aug2023, Vol. 15 Issue 16, p4034. 17p.

Anti-tumor immunity in a model of acute myeloid leukemia.

Authors: Cheuk, Adam T. C. Wells, James W. Chan, Lucas et al.

Source: Leukemia & Lymphoma. Mar2009, Vol. 50 Issue 3, p447-454. 8p. 4 Graphs.

Targeting Wild-Type and Mutationally Activated FGFR4 in Rhabdomyosarcoma with the Inhibitor Ponatinib (AP24534).

Authors: Li, Samuel Q. Cheuk, Adam T. Shern, Jack F. et al.

Source: PLoS ONE. Oct2013, Vol. 8 Issue 10, p1-9. 9p.

Role of 4-1BB:4-1BB ligand in cancer immunotherapy.

Authors: Cheuk, Adam T. C. Mufti, Ghulam J. Guinn, Barbara-ann

Source: Cancer Gene Therapy. Mar2004, Vol. 11 Issue 3, p215-226. 12p.

Massively Parallel Sequencing Reveals an Accumulation of De Novo Mutations and an Activating Mutation of LPAR1 in a Patient with Metastatic Neuroblastoma.

Authors: Wei, Jun S. Johansson, Peter Chen, Li et al.

Source: PLoS ONE. Oct2013, Vol. 8 Issue 10, p1-1. 1p.